Compare MKS Instruments (MKSI) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MKS Instruments vs Nuvation Bio Inc. Class A Common Stock — how do they compare? MKS Instruments trades at $265.61 (market cap $17.61B), while Nuvation Bio Inc. Class A Common Stock trades at $4.99 (market cap $1.74B). The key difference: MKS Instruments is far larger — about 10.1× Nuvation Bio Inc. Class A Common Stock's market cap, and MKS Instruments pays a 0.38% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold MKS Instruments for 7 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| MKSI | NUVB | |
|---|---|---|
Market Cap | $17.61B | $1.74B |
Volume | 1,275,355 | 9,289,619 |
Sector | Technology | Health |
52-Week High | $444.80 | $9.54 |
52-Week Low | $121.26 | $3.41 |
Typical Hold Time | 7 Days | 1 Days |
Enterprise Value | $21.18B | $1.33B |
Dividend Yield | 0.38% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About MKS Instruments
MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
